User Fee Hike Will Give Sponsors Clarity On Label, Postmarketing Discussions
Executive Summary
As part of its recommendations for the renewal of the user fee program, FDA is proposing refinements to its "74-day letters" to give sponsors a more detailed schedule of how the application review will proceed
You may also be interested in...
User Fee Inflation Calculations May Need To Change Due To Slow Economic Recovery
The groggy U.S. economy, which already is forcing cut-backs and pay freezes for federal workers, also may push FDA and industry to rethink how to calculate user fee revenue.
User Fee Inflation Calculations May Need To Change Due To Slow Economic Recovery
The groggy U.S. economy, which already is forcing cut-backs and pay freezes for federal workers, also may push FDA and industry to rethink how to calculate user fee revenue.
FDA Wants Promotional “Targets” From Sponsors Throughout Drug Development
Sponsors should provide FDA with proposed promotional claims at the beginning of the drug development process, the agency said in a draft guidance